Suppression of Interferon-α Treatment Response by Host Negative Factors in Hepatitis B Virus Infection
Chronic hepatitis B virus (CHB) infection remains a major global public health issue for which there is still lacking effective curative treatment. Interferon-α (IFN-α) and its pegylated form have been approved as an anti-HBV drug with the advantage of antiviral activity and host immunity against HB...
Guardado en:
Autores principales: | Jiayi Wang, Lingyao Du, Hong Tang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/71acc532ea334bc291e7c65f66355067 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Trastornos psiquiátricos y cognitivos de la hepatitis C y su tratamiento con interferón
por: CANEO R,CONSTANZA, et al.
Publicado: (2010) -
El virus C de la hepatitis y las enfermedades que produce
por: Armas-Merino,Rodolfo, et al.
Publicado: (1999) -
Suppression and Activation of Intracellular Immune Response in Initial Severe Acute Respiratory Syndrome Coronavirus 2 Infection
por: Lijia Jia, et al.
Publicado: (2021) -
EFFECT OF DEXAMETHASONE ON INTERFERON-α-INDUCED DIFFERENTIATION OF MONOCYTES TO DENDRITIC CELLS
por: Yu. D. Kurochkina, et al.
Publicado: (2016) -
A Missense Variant in Granulysin is Associated with the Efficacy of Pegylated-Interferon-Alpha Therapy in Chinese Patients with HBeAg-Positive Chronic Hepatitis B
por: Li J, et al.
Publicado: (2021)